Scientists from Skoltech and the University of Potsdam have developed a physical theory that sheds light on how molecular ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
Serially cloned mice hit a genetic “dead end” by generation 58, underscoring that sex evolved for variation, purging harmful ...
The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...
A system to enrich yeast in metaphase of mitosis, meiosis I, or meiosis II reveals reduced spindle assembly checkpoint robustness in meiosis I and distinct kinetochore composition and phosphorylation ...
The FDA has granted fast track and rolling review status to Celltrion’s CT-P71, a Nectin-4 targeting ADC for treating ...
Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, ...
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
God created Adam and Eve. God also created diversity, variation, abundance, evolution, meiosis, mitosis, DNA replication and parthenogenesis (John 1:3). The names we apply to these states and phenomen ...
Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.
San Gabriel-based Vesicor Therapeutics Inc., which is developing solid tumor cancer therapies that can be delivered through ...
"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results